BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18030581)

  • 41. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
    Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences.
    Drent M; Wagenaar SS; Mulder PH; van Velzen-Blad H; Diamant M; van den Bosch JM
    Chest; 1994 Feb; 105(2):514-9. PubMed ID: 7905815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.
    Delforge A; Bernier M; Bosmans E; Massy M; Bron D; Heyligen H; Raus J; Mendes Da Costa P; Stryckmans P
    Leuk Lymphoma; 1991; 3(5-6):385-93. PubMed ID: 27467429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
    Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
    PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome.
    Fabre-Guillevin E; Tabrizi R; Coulon V; Monnereau A; Eghbali H; Soubeyran I; Soubeyran P
    Leuk Lymphoma; 2006 Apr; 47(4):603-11. PubMed ID: 16690518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The performance of the automated immune chemiluminescent system "IMMULITE 2000XPi for the measurement of serum soluble IL-2 receptor in clinical samples].
    Watanabe N; Nagatomo R; Okubo S; Yokota H; Masuda A; Ikeda H; Yatomi Y
    Rinsho Byori; 2012 May; 60(5):422-8. PubMed ID: 22774570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy.
    Chen W; Zhang Q; Li M; Huang G; Guo L; Chen Z; Ding Q; Gu Y
    Clin Chim Acta; 2023 May; 545():117372. PubMed ID: 37127231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Florid epithelioid cell and sarcoid-type reaction associated with non-Hodgkin's lymphoma.
    Kahn LB; King H; Jacobs P
    S Afr Med J; 1977 Mar; 51(11):341-7. PubMed ID: 577052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low level of serum HDL-cholesterol with increased sIL-2R predicts a poor clinical outcome for patients with malignant lymphoma and adult T-cell leukemia-lymphoma.
    Komiya I; Tomoyose T; Ouchi G; Yara T; Higa S
    Cytokine; 2018 May; 105():57-62. PubMed ID: 29459344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imitating the Great Imitator The Intersection of Sarcoidosis and Hodgkin's Lymphoma A Report of Two Cases.
    Outlaw D; Mehta A; Dalvi SR
    Bull Hosp Jt Dis (2013); 2018 Jun; 76(2):143-148. PubMed ID: 29799375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of laparoscopy with liver biopsy in the assessment of liver involvement at diagnosis of Hodgkin's and non-Hodgkin's lymphomas.
    Sans M; Andreu V; Bordas JM; Llach J; López-Guillermo A; Cervantes F; Bruguera M; Mondelo F; Montserrat E; Terés J; Rodés J
    Gastrointest Endosc; 1998 May; 47(5):391-5. PubMed ID: 9609433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT].
    Stroszczynski C; Amthauer H; Hosten N; Mapara M; Ricke J; Jochens R; Fischer-Funk E; Ludwig WD; Eichstädt H; Felix R
    Rofo; 1997 Nov; 167(5):458-66. PubMed ID: 9440890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
    Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
    Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
    Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
    Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas.
    Stasi R; Conforti M; Del Poeta G; Simone MD; Coppetelli U; Tribalto M; Cantonetti M; Perrotti A; Venditti A; Papa G
    Haematologica; 1992; 77(6):518-21. PubMed ID: 1289190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features.
    Chilosi M; Semenzato G; Vinante F; Menestrina F; Piazzola E; Focchiatti V; Sabbioni R; Zanotti R; Pizzolo G
    Am J Clin Pathol; 1989 Aug; 92(2):186-91. PubMed ID: 2667328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum levels of soluble interleukin-2 receptor in renal cell carcinoma.
    Matsumoto T; Furukawa A; Sumiyoshi Y; Akiyama KY; Kanayama HO; Kagawa S
    Urology; 1998 Jan; 51(1):145-9. PubMed ID: 9457310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.